Page 4 - Division Of Blood News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ImmPACT Bio Names Jonathan Benjamin, M D , Ph D as Chief Medical Officer

/PRNewswire/ ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR).

Stanford universityUnited statesSan franciscoSumant ramachandraJonathan benjaminUniversity of californiaAtreca incPrnewswire immpact bio united states incAmgen incHarvard collegeYork universityDivision of bloodBio united statesMarrow transplantStanford university schoolNew york university

2022 Health Care Heroes: Dr Paul Orchard develops life-saving gene therapy treatment - Minneapolis / St Paul Business Journal

2022 Health Care Heroes: Dr Paul Orchard develops life-saving gene therapy treatment - Minneapolis / St Paul Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of minnesotaDrug administrationM health fairviewDivision of bloodRare disease advisory committeeUniversity of minnesota medical schoolBrown university program in medicineDepartment of pediatricsStorage disease programPaul orchardInherited metabolicMinnesota medical schoolMarrow transplantMinnesota medicalBrown university program

Gamida Cell (GMDA) Presents Updated Omidubicel Data

Gamida Cell (GMDA) Presents Updated Omidubicel Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Salt lake cityUnited statesPaul szabolcsRonit simantovGamida cell ltdDivision of bloodCellular therapy meetingsAbstract awardStem cell transplantationEnhanced circulatory plasmacytoid dendritic cellsSlower ratesSevere infections comparedStandard umbilical cord blood transplantationMarrow transplantationCellular therapyChief medical officer

Jasper Therapeutics Announces Management Changes to Strengthen Leadership Team

REDWOOD CITY, Calif., March 21, 2022 Jasper Therapeutics, Inc. , a biotechnology company focused on hematopoietic cell transplant therapies, today announced changes to its management team,. | March 21, 2022

United statesJohn mullalyRonald martellKevin hellerJudith shizuruStrategic marketing at portola pharmaceuticalsIllinois institute of technologyJasper therapeutics incProduct developmentHarvard universityStanford immunology programCarolina state universityBennington collegeGlobenewswire incInstitute for stem cell biologyDivision of blood

Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesSalt lake cityPaul szabolcsCourtney turianoDima yackoubovRichard maziarzRhiannon jeselonisNavneet majhailUsama gergisMitchell horwitzChenyu linDuke cancer instituteAmerican society of hematology annual meetingStern investor relations incSingle centerOregon health